The week in pharma: action, reaction and insight – week to April 17, 2026 | The Pharmaletter

Among regulatory news last week, US biotech Replimune had another US Food and Drug Administration (FDA) setback for its investigational cancer …

By AJDesign77|2026-04-19T13:30:34+00:00April 19th, 2026|Uncategorized|0 Comments

About the Author: AJDesign77

Related Posts

FDA Commissioner Makary on the ropes after months of turmoil | Cascade PBS
FDA Commissioner Makary on the ropes after months of turmoil | Cascade PBS
Trump Asked To His Face: ‘Are You Bringing Someone New In To Lead The FDA?’
Trump Asked To His Face: ‘Are You Bringing Someone New In To Lead The FDA?’
Massive drug busts in California, Texas, enough to kill more than 32.7 million people
Massive drug busts in California, Texas, enough to kill more than 32.7 million people
Legislators Denounce “Appalling and Horrific Treatment” of Mothers in Immigrant Detention
Legislators Denounce “Appalling and Horrific Treatment” of Mothers in Immigrant Detention
Big Bend border wall plans cancelled for national park after backlash – News 4 San Antonio
Big Bend border wall plans cancelled for national park after backlash – News 4 San Antonio